Story · Nutrition

Why don’t GLP-1 obesity drugs work for everyone?

2 outlets · first reported by The Conversation Canada Health on · latest · 24 hours of coverage · 2 countries

Medications like Ozempic and Wegovy, which contain semaglutide — a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight — have become household names and important pillars in obesity management for the medical profession. Research has shown GLP-1 medications reduce body… (The Conversation Canada Health)

Coverage, in order

  1. first The Conversation Canada Health Canada indie
    Why don’t GLP-1 obesity drugs work for everyone?

    Medications like Ozempic and Wegovy, which contain semaglutide — a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight — have become household names and important pillars in obesity management for the medical profession. Research has shown GLP-1 medications reduce body…

  2. Why don't GLP‑1 obesity drugs work for everyone?

    Medications like Ozempic and Wegovy, which contain semaglutide—a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight—have become household names and important pillars in obesity management for the medical profession.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.